Authors


RYAN W. STEVENS, PHARMD, BCPS

Latest:

Candida Auris: The Rise of a New Fungal Threat

Candida auris—Are we prepared for another multidrug-resistant pathogen?



Doe Kley, RN, MPH

Latest:

What Health Care Providers Need to Know About 2019-nCoV Now

The CDC, WHO, and other global entities are working together to understand and control this novel coronavirus and provide important guidelines for health care professionals. Here’s what you should know.


Kristen Coppock, MA

Latest:

Pharmacist Intervention and Continued HIV Care: Examining the Connection

Could pharmacist-led medication reconciliation improve inpatient continuity of care in individuals with HIV?


Frank Diamond

Latest:

CDC Unveils 'Test-to-Stay' COVID-19 School Strategy to Limit Quarantines

Children in the United States will be able to avoid potentially millions of hours of at-home quarantining under a testing program unveiled by the CDC today.


Laura Alfonso, BSN, RN, OCN

Latest:

Evidence-Based Intervention Reduces C. diff Rates in Adults With Cancer

SMUCLA implements high-touch wipe down intervention to address the need for environmental disinfection of cancer patient care areas.




Khalid Eljaaly, PharmD, BCPS, MS

Latest:

Lack of Benefit of Azithromycin Use in Acute Asthma Exacerbations

Recent research shows no clinical benefits from adding azithromycin to standard treatment for adults who presented to emergency departments with acute asthma exacerbations requiring a corticosteroid course.


MS Candidate

Latest:

Four Fungal Horsemen: Emerging Trends in Fungal Disease Epidemiology

New public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.


Maureen Taylor, CCPA, BHSc

Latest:

FMT Proves to Be Effective and Acceptable Treatment for rCDI

Fecal microbiota transplantation (FMT) is a widely accepted, safe, and effective treatment for recurrent Clostridium diffi­cile infection (rCDI), but does the cure endure?


PAUL SALEEB, MD, FACP

Latest:

Exploring the Threat of MDR-TB in the United States

The virulent pathogen has significant individual and public health implications.


Elizabeth D. Hermsen, PharmD, MBA

Latest:

Pharmaceutical Companies and Antimicrobial Stewardship: Save Us a Seat

The pharmaceutical industry plays an essential role in advancing antimicrobial stewardship and addressing the growing threat of resistant pathogens.


Nicole Brandt, PharmD, MBA, BCPP, CGP, FASCP

Latest:

A Long-Term Care Antimicrobial Stewardship Certificate Program for Pharmacists: Filling an Unmet Need

This training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.


Kim Claeys, PharmD

Latest:

Novel Cephalosporin Agent Shows Promise for Complicated UTIs

A new agent in the antibiotic pipeline, cefiderocol, has proved to be effective against complicated urinary tract infections (UTIs).


MONIQUE A. FOSTER, MD, MPH

Latest:

Hepatitis A Outbreaks on the Rise in the US

An epidemiologist explores the changing epidemiology of a familiar disease.


Laurie Anne Walden, DVM, ELS

Latest:

Psychobiotics: What Do We Know and Where Do We Go?

Review authors discuss current knowledge regarding psychobiotics and identify questions for future research.


Jamie Kisgen, PharmD, BCPS-AQ ID

Latest:

Staying Ahead of the Curve: Implementing AUC-Guided Vancomycin Dosing

Evidence suggests AUC-guided vancomycin dosing is a safer method than traditional trough-guided dosing.


Einav Keet

Latest:

An Estimated 5700 Zika Cases Went Unreported in 2017 Cuban Outbreak

Although Cuba reported no cases of Zika virus in 2017 and 2018, investigators used travel data and genomic epidemiology to uncover a large, “hidden” Zika outbreak.


Danielle Mroz

Latest:

SEP-1 Bundle Compliance Associated with Reduced Hospital Readmissions

As the leading cause of unplanned 30-day hospital readmissions, sepsis affects more than 1.5 million individuals each year.


Brendan R. Jackson, MD, MPH

Latest:

Candida auris: Coming Soon to a Facility Near You?

Epidemiologic and clinical lessons for the uninitiated.



MARLEE A. MANGINO, PHARMD

Latest:

Transition to Oral Therapy for the Treatment of Bacteremic Urinary Tract Infections

Several recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.


Adriano de Bernardi Schneider, MS

Latest:

Phylogenetically Mapping the Evolution of the Zika Virus as It Spread Across the World

Adriano de Bernardi Schneider, MS, PhD Candidate, Contagion® Editorial Advisory Board Member, provides a brief snapshot into some of his work on mapping the evolution of the Zika virus.


BY DEBRA GOFF, PHARMD**

Latest:

Teaching Old Dogs New Tricks: Make the Most of Twitter to Boost ID Education, Engagement, and Advocacy

Infectious diseases clinicians turn to Twitter as a tool for education and collaboration.



Thy N. Le, PharmD, BCPS-AQ-ID

Latest:

Update on Candida auris: Statistics, Detection, and a Phase 2 Trial

As of October 31, 2018, the CDC has reported 457 clinical cases of confirmed C auris infection with a majority in New York (>50%), New Jersey, and Illinois.


MARILYN MOOTZ, PHARMD

Latest:

Long-Acting Anti-MRSA Agents: One Dose to Cure?

A review of the current literature and future directions.



Grant M. Gallagher

Latest:

Texas State Scientist on Rabies Eradication, Campus Reopening, and AMR

Dr. Rodney E. Rohde, clinical laboratory scientist, discusses campus reopening as well as his work on rabies eradication.

© 2023 MJH Life Sciences

All rights reserved.